MAGNOLITA PHILIP-ROUSSEAU: Open Payments
NPI 1689022279 · BAYONNE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$172 in 10 payments from 8 companies in 2025. Trend: 2023 $70 · 2024 $14 · 2025 $172
Food & beverage: $172
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $32 |
| ABBVIE INC. | 2 | $30 |
| Corcept Therapeutics | 1 | $20 |
| Alkermes, Inc. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Forte Bio-Pharma LLC | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| Valinor Pharma, LLC | 1 | $16 |
Products named: MOUNJARO, CREON, Korlym, VIVITROL, Kerendia, PROLATE, RELISTOR, MOVANTIK.
Industry payments across NJ — which companies pay providers there.
